Contact us
About company
Replicor is a clinical-stage biopharmaceutical company developing NUCLEIC ACID POLYMERS (NAPs). These compounds are oligonucleotides whose antiviral activity is strictly dependent on the sequence independent activity of phosphonothioate oligonucleotides as biocompatible polymers that interact with exposed hydrophobic surfaces in proteins.
CA
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews